Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences
Go back to Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences| Abbott Laboratories (NYSE: ABT) | Delayed: 90.65 +2.82 (3.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $87.83 | 52 Week High | $46.38 | |||
| Open | $88.95 | 52 Week Low | $36.00 | |||
| Day High | $90.93 | P/E | 60.43 | |||
| Day Low | $88.73 | EPS | $1.50 | |||
| Volume | 6,383,239 | |||||
